| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000049467 |
| Receipt No. | R000056325 |
| Scientific Title | Verification of the effect of breast massage care on breast engorgement |
| Date of disclosure of the study information | 2023/01/01 |
| Last modified on | 2022/11/09 (Ver. 1) |
| Basic information | ||
| Public title | Verification of the effect of breast massage care on breast engorgement | |
| Acronym | Verification of the effect of breast massage care on breast engorgement | |
| Scientific Title | Verification of the effect of breast massage care on breast engorgement | |
| Scientific Title:Acronym | Verification of the effect of breast massage care on breast engorgement | |
| Region |
|
|
| Condition | ||
| Condition | Women who have a normal pregnancy and delivery process for both mother and child and wish to breastfeed. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The course of breast engorgement symptoms that appeared in the early postpartum period will be clarified in relation to changes in udder findings and intramammary blood flow. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Axillary, lateral thoracic, and medial thoracic arteriovenous blood flow
(around 36 weeks gestation, 1st, 3rd, and 5th days postpartum) Evaluate twice on the third postpartum day only: before breast massage and after massage and breastfeeding. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Planned vaginal delivery of a single fetus | |||
| Key exclusion criteria | Women with psychiatric complications, abnormal glucose metabolism, cardiac disease, history of hypertension, and history of breast disease and its surgery
|
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shiga University of Medical Science | ||||||
| Division name | Course of Nursing | ||||||
| Zip code | 5202144 | ||||||
| Address | Seta Tsukinawa-cho, Otsu City, Shiga | ||||||
| TEL | 0775482111 | ||||||
| ytateoka@belle.shiga-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shiga University of Medical Science | ||||||
| Division name | Course of Nursing | ||||||
| Zip code | 5202144 | ||||||
| Address | Seta Tsukinawa-cho, Otsu City, Shiga | ||||||
| TEL | 0775482111 | ||||||
| Homepage URL | |||||||
| ytateoka@belle.shiga-med.ac.jp | |||||||
| Sponsor | |
| Institute | Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shiga University of Medical Science |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shiga University of Medical Science |
| Address | Seta Tsukinawa-cho, Otsu City, Shiga |
| Tel | 0775482111 |
| ytateoka@belle.shiga-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056325 |